These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16706550)

  • 1. Gram-positive cocci infections in intensive care: guide to antibacterial selection.
    Alvarez-Lerma F; Grau S; Gracia-Arnillas MP
    Drugs; 2006; 66(6):751-68. PubMed ID: 16706550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GEIPC-SEIMC (Study Group for Infections in the Critically Ill Patient of the Spanish Society for Infectious Diseases and Clinical Microbiology) and GTEI-SEMICYUC ( Working Group on Infectious Diseases of the Spanish Society of Intensive Medicine, Critical Care, and Coronary Units) recommendations for antibiotic treatment of gram-positive cocci infections in the critical patient].
    Astigarraga PM; Montero JG; Cerrato SG; Colomo OR; Martínez MP; Crespo RZ; García-Paredes PM; Cerdá EC; Lerma FA
    Enferm Infecc Microbiol Clin; 2007; 25(7):446-66. PubMed ID: 17692213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient].
    Alvarez-Lerma F; Gracia-Arnillas MP
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():29-35. PubMed ID: 21477702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of linezolid in critically ill patients admitted to intensive care units.
    Rodríguez O; Alvarez F; Oltra R; Cereijo E; Latorre MM; Martínez H;
    Rev Esp Quimioter; 2009 Jun; 22(2):68-75. PubMed ID: 19554485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GEIPC-SEIMC and GTEI-SEMICYUC recommendations for antibiotic treatment of gram positive coccal infections in the critical patient].
    Olaechea Astigarraga PM; Garnacho Montero J; Grau Cerrato S; Rodríguez Colomo O; Palomar Martínez M; Zaragoza Crespo R; Muñoz García-Paredes P; Cerdá Cerdá E; Alvarez Lerma F; ;
    Med Intensiva; 2007; 31(6):294-317. PubMed ID: 17663956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for management of resistant Gram-positive infections: from S. pneumoniae to MRSA].
    Cristini F
    Infez Med; 2007 Sep; 15 Suppl 2():13-9. PubMed ID: 17940408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated approach to healthcare-associated meningitis.
    Bardak-Ozcem S; Sipahi OR
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):333-42. PubMed ID: 24512210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection.
    Hautala T; Syrjälä H; Lehtinen V; Kauma H; Kauppila J; Kujala P; Pietarinen I; Ylipalosaari P; Koskela M
    Int J Antimicrob Agents; 2005 Apr; 25(4):329-33. PubMed ID: 15784313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction: treatment of Gram-positive infections.
    Wise R
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii5-7. PubMed ID: 12797336
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A re-emerging class of antimicrobial agents: streptogramins (quinupristin/dalfopristin) in the management of multiresistant gram-positive nosocomial cocci in hospital setting.
    Manfredi R
    Mini Rev Med Chem; 2005 Dec; 5(12):1075-81. PubMed ID: 16375753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia].
    Espinosa CJ; Cortés JA; Castillo JS; Leal AL
    Biomedica; 2011 Mar; 31(1):27-34. PubMed ID: 22159481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapeutic options for infections caused by drug-resistant Gram-positive cocci.
    Banwan K; Senok AC; Rotimi VO
    J Infect Public Health; 2009; 2(2):62-73. PubMed ID: 20701863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.
    Barcenilla F; Gascó E; Rello J; Alvarez-Rocha L
    Drugs Aging; 2001; 18(3):189-200. PubMed ID: 11302286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis.
    Smith PB; Cotten CM; Garges HP; Tiffany KF; Lenfestey RW; Moody MA; Li JS; Benjamin DK
    J Perinatol; 2006 Feb; 26(2):111-4. PubMed ID: 16435007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Enterococcus as a significant pathogen.
    Moellering RC
    Clin Infect Dis; 1992 Jun; 14(6):1173-6. PubMed ID: 1623072
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.